Anthony Cheung
Fondateur chez ENGENE HOLDINGS INC.
Fortune : 904 254 $ au 31/05/2024
Provenance du réseau au premier degré de Anthony Cheung
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 11 | |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada.
9
| Subsidiary | Biotechnology | 9 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Anthony Cheung via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor Private Equity Investor | |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO General Counsel | |
University of Groningen | College/University | Graduate Degree Doctorate Degree | |
Prexton Therapeutics SA
Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Prexton Therapeutics SA operates as a biopharmaceutical company which develops novel therapeutic compounds as a new treatment for Parkinson’s disease and other brain disorders. The company was founded by Francois Conquet in 2012 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Private Equity Investor Private Equity Investor | |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Director of Finance/CFO | |
Mallinckrodt Medical, Inc.
Mallinckrodt Medical, Inc. Medical SpecialtiesHealth Technology Mallinckrodt Medical, Inc. manufactures and markets healthcare products. Its products include contrast media & delivery systems, radiology imaging products, radiopharmaceuticals and urology imaging systems. The company is headquartered in Pointe-Claire, Canada. | Medical Specialties | Director of Finance/CFO | |
XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
Multiple Myeloma Canada
Multiple Myeloma Canada Miscellaneous Commercial ServicesCommercial Services Multiple Myeloma Canada engages in the clinical research. It focuses on myeloma, a cancer of the plasma cells found in the bone marrow. The company was founded by Aldo Del Col in 2005 and is headquartered in Dorval, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Aerogen Ltd.
Aerogen Ltd. Medical SpecialtiesHealth Technology Aerogen Ltd. develops and manufactures aerosol products. It offers Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-X controller and USB controller. The company was founded by John S. Power in 1997 and is headquartered in Galway, Ireland. | Medical Specialties | Director/Board Member | |
FUSN PHAR | Pharmaceuticals: Major | Director/Board Member | |
2941881 Canada, Inc.
2941881 Canada, Inc. Medical SpecialtiesHealth Technology 2941881 Canada, Inc. manufactures and supplies pelvic health and gastrointestinal equipment and consumables. The company was founded by Raymond George Yves Laborie in 1967 and is headquartered in Mississauga, Canada. | Medical Specialties | Director/Board Member | |
Altasciences Co., Inc.
Altasciences Co., Inc. Miscellaneous Commercial ServicesCommercial Services Altasciences Co., Inc. engages in the provision of clinical pharmacology development services. It offers bioanalysis and research services, preclinical services, clinical services, and development programs. The company was founded in 1992 and is headquartered in Laval, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
NewAmsterdam Pharma BV
NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Medical/Nursing Services | Director/Board Member | |
Aptalis Holdings, Inc.
Aptalis Holdings, Inc. Pharmaceuticals: MajorHealth Technology Aptalis Holdings Inc. operates as a holding company that develops, manufactures, licenses, markets and distributes therapies for unmet medical needs. It includes cystic fibrosis and gastrointestinal disorders through its subsidiaries. It also formulates and clinically develops enhanced pharmaceutical, biopharmaceutical products for itself and others using its proprietary technology platforms including bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking and orally disintegration tablet formulations. The company was founded on January 10, 2008 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
Swiss Federal Institute of Technology | College/University | Doctorate Degree | |
Akarna Therapeutics Ltd.
Akarna Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Akarna Therapeutics Ltd. develops novel small molecule therapeutics. It offers non-bile acid FXR agonist, a therapeutic for the treatment of nonalcoholic steatohepatitis and fatty-liver diseases. The company was founded by Raju Mohan in 2014 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Generic | Director/Board Member | |
MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
DSM Pharmaceutical Products, Inc.
DSM Pharmaceutical Products, Inc. Chemicals: Major DiversifiedProcess Industries Part of Thermo Fisher Scientific, Inc., DSM Pharmaceutical Products, Inc. is a science-based company that specializes in nutrition, health, and bioscience. The company is based in Parsippany, NJ. The company offers solutions for animal nutrition, human nutrition and care, food and beverage, and materials. DSM's companies cover a range of human and animal health and nutrition businesses. DSM's investor relations team provides key facts and figures, as well as shareholder information, to current and potential shareholders of DSM and to analysts. | Chemicals: Major Diversified | Corporate Officer/Principal | |
VectorY BV
VectorY BV Miscellaneous Commercial ServicesCommercial Services VectorY BV is a biotech company based in Amsterdam, Netherlands, that is dedicated to developing transformative medicines for people with neurodegenerative diseases such as ALS, Huntington's, and Parkinson's. VectorY's platform combines the promise of precise therapeutic antibodies with one-time AAV-based delivery to the CNS, enabling long-lasting CNS treatment after a single administration using cutting-edge antibody, AAV, and manufacturing technologies. The Dutch company's unique in-house expertise in antibodies, AAV vectors, protein degradation, manufacturing, and neuroscience drives the rapid development of much-needed disease-modifying therapies for neurodegenerative diseases. The company was founded by Sander J. van Deventer and Pavlina Konstantinova, with Sander J. van Deventer serving as the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Rectify Pharmaceuticals LLC
Rectify Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Rectify Pharmaceuticals LLC is a biotech company that is developing positive functional modulators (PFMs) to address the underlying cause of serious ABC transporter-mediated diseases. The company is based in Cambridge, MA and was founded by Jonathan Moore. The company's team includes Xiaobing Li as Chief Development Officer, Robert Hughes as Executive Vice President of Drug Discovery and Preclinical Development, and Leif-Ann Tuohey as Senior Vice President and Head of Business Development. The company has received $100 million in Series A financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund. The CEO is Rajesh Devraj, who is also a venture partner at Atlas Venture. | Miscellaneous Commercial Services | Director/Board Member | |
ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Director/Board Member | |
Aptalis Pharma LLC
Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | Pharmaceuticals: Major | Director of Finance/CFO | |
Inversago Pharma, Inc.
Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Kearny Venture Partners
Kearny Venture Partners Investment ManagersFinance Kearny Venture Partners (Kearny Venture Partners) is a venture capital firm. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Vancouver Aquarium
Vancouver Aquarium Miscellaneous Commercial ServicesCommercial Services Part of Herschend Family Entertainment Corp., Vancouver Aquarium operates an aquarium. The company is based in Vancouver, Canada. Vancouver Aquarium was acquired by Herschend Family Entertainment Corp. from Ocean Wise Conservation Association on April 15, 2021. The Canadian company was founded in 1951. | Miscellaneous Commercial Services | Director/Board Member | |
viDA Therapeutics, Inc.
viDA Therapeutics, Inc. BiotechnologyHealth Technology viDA Therapeutics, Inc. operates as a biotechnology company. It offers discovery, development and commercialization of novel and targeted therapeutics for the treatment of inflammatory and age related diseases. The firm's discovery platform is based on novel research regarding a distinctly different and recently identified, extracellular role for granzymes in the destruction and inflammation of tissues. The company was founded by Alistair Duncan Jr. and David Granville in 2008 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member | |
Canadian Genetic Disease Network | Director/Board Member | ||
Probtec Corp. | Founder | ||
Ontario Molecular Diagnostics | Founder | ||
VIGIL HEALTH | Computer Communications | Chairman | |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Chairman | |
Innovate BC
Innovate BC Miscellaneous Commercial ServicesCommercial Services Innovate BC develops entrepreneurial talent and supports commercializing technology. The firm focuses on competitively positioning British Columbia in today's global knowledge economy in order to provide significant employment opportunities and a high standard of living for British Columbians. The company was founded in 1978 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Concordia University | College/University | Undergraduate Degree | |
ESSA PHARMA INC. | Pharmaceuticals: Major | Chairman | |
BC Biotech
BC Biotech Investment Trusts/Mutual FundsMiscellaneous BC Biotech is a Canadian biotechnology company that works in the field of applied biology, using engineering, medicine, and technology in conjunction with living organisms and bioprocesses. BC Biotech also provides information on how to study biotechnology in school and which institutions are known for their program. The non-profit company is based in Vancouver, Canada. The company aims to promote businesses in the biotechnology industry and inform people about the science behind it. | Investment Trusts/Mutual Funds | Chairman | |
Stressgen Biotechnologies Corp. /Bioreagents Business/ | Biotechnology | Chief Executive Officer | |
Vida Pharmaceuticals Pvt Ltd. | Director/Board Member | ||
EUPRAXIA PHARMACEUTICALS INC. | Biotechnology | Director/Board Member | |
Aurinia Pharma Corp.
Aurinia Pharma Corp. Drugstore ChainsRetail Trade Part of Aurinia Pharmaceuticals, Inc., Aurinia Pharma Corp. operates pharmacies. The company is based in Victoria, Canada. The Canadian company was founded by Richard M. Glickman. | Drugstore Chains | Chief Executive Officer | |
University of British Columbia | College/University | Corporate Officer/Principal | |
Oxitope Pharma BV
Oxitope Pharma BV Pharmaceuticals: MajorHealth Technology Oxitope Pharma BV is a Dutch pharmaceutical start-up founded in 2020 that focuses on discovering and developing medicine for the treatment of inflammatory and cardiovascular diseases caused by oxidative stress. The company is based in Naarden, Netherlands. The Dutch company takes a different approach to the diagnosis and treatment of these diseases by preventing, halting, or reversing acute and chronic diseases driven by oxidized phospholipids. Oxitope Pharma's goal is to enable people to live long and healthy lives. The CEO is John Montana. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
Canada | 29 |
Etats-Unis | 10 |
Pays-Bas | 6 |
Suisse | 2 |
Irlande | 2 |
Sectorielle
Health Technology | 27 |
Commercial Services | 8 |
Consumer Services | 5 |
Finance | 4 |
Health Services | 2 |
Opérationnelle
Director/Board Member | 112 |
Corporate Officer/Principal | 36 |
Independent Dir/Board Member | 33 |
Chairman | 17 |
Chief Tech/Sci/R&D Officer | 14 |
Relations les plus connectées
Insiders | |
---|---|
Dennis Langer | 40 |
Richard Glickman | 26 |
Gerry Brunk | 25 |
Lota Zoth | 20 |
Marco Boorsma | 15 |
Jasper Bos | 15 |
Richard Bryce | 15 |
Jason Hanson | 14 |
Steven Gannon | 14 |
Ryan Daws | 9 |
lee Giguere | 8 |
Andrei Vladimirovich Petrov | 7 |
Alexander Nichols | 7 |
James Sullivan | 7 |
Alexandre Grassin | 6 |
- Bourse
- Insiders
- Anthony Cheung
- Connexions Sociétés